[144] Vita Coco Company, Inc. SEC Filing

Rhea-AI Filing Summary

Vita Coco Company, Inc. (COCO) filing of Form 144 reports a proposed sale of 21,700 common shares by an insider acquired as stock compensation on 07/12/2016. The filing lists the broker as The Charles Schwab Corporation and shows an aggregate market value of $1,068,399.00 for the proposed sale with an approximate sale date of 09/17/2025 on NASDAQ. The filer also disclosed two prior sales by the same person totaling 7,800 shares during July and August 2025 that generated combined gross proceeds of $285,088.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Financial Analyst

Insider plans a modest stock sale; transaction appears routine and non-fundamental.

The seller intends to sell 21,700 shares valued at about $1.07 million through Charles Schwab on NASDAQ. The shares were originally received as stock compensation in 2016, indicating a long holding period prior to these transactions. Recent attested sales of 7,800 shares in July and August 2025 generated roughly $285k, showing prior liquidation activity but not a large divestiture relative to total outstanding shares (56,822,981 reported outstanding).

Corporate Governance Expert

Disclosure follows procedural requirements; no governance red flags in filing itself.

The Form 144 includes required broker, acquisition, and sale-history details and the seller's certification regarding material non-public information. The acquisition was via issuer stock compensation and the seller affirmed no undisclosed material adverse information. The filing does not state any trading plan date or 10b5-1 adoption, and it does not indicate any unusual transfer mechanisms or related-party arrangements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	21700	1068399.00	56822981	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	07/12/2016	STOCK COMPENSATION	ISSUER			21700	07/12/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kenneth Sadowsky 250 Park Avenue South Seventh Floor New York NY 10003	COMMON	07/16/2025	3900	146842.00
Kenneth Sadowsky 250 Park Avenue South Seventh Floor New York NY 10003	COMMON	08/20/2025	3900	138246.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vita Coco's (COCO) Form 144 report say about the planned sale?

The Form 144 reports a proposed sale of 21,700 common shares with an aggregate market value of $1,068,399.00, to be sold approx. on 09/17/2025 on NASDAQ.

Who is the broker handling the proposed sale in the Form 144?

The broker listed is The Charles Schwab Corporation located at 3000 Schwab Way, Westlake TX.

How and when were the shares being sold acquired?

The 21,700 shares were acquired as stock compensation from the issuer on 07/12/2016.

Has the seller made other sales recently according to the filing?

Yes. The filing discloses two sales: 3,900 shares on 07/16/2025 for $146,842.00 and 3,900 shares on 08/20/2025 for $138,246.00.

Does the Form 144 indicate any undisclosed material information about Vita Coco?

The seller represents by signature that they do not know any material adverse information that has not been publicly disclosed.